Cargando…

Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis

PURPOSE: In pulmonary oligometastases from colorectal cancer (POM-CRC), the primarily recommended local therapy is metastasectomy. Stereotactic body radiotherapy (SBRT) is another local therapy modality that is considered as an alternative option in patients who cannot undergo surgery. The purpose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Hoon Sik, Jeong, Bae Kwon, Kang, Ki Mun, Jeong, Hojin, Song, Jin Ho, Ha, In Bong, Kwon, Oh-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577807/ https://www.ncbi.nlm.nih.gov/pubmed/32718145 http://dx.doi.org/10.4143/crt.2020.402

Ejemplares similares

Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases
por: Lee, Yun Hee, et al.
Publicado: (2018)

Role of radiotherapy in the management of malignant airway obstruction
por: Choi, Hoon Sik, et al.
Publicado: (2020)

Analysis of Motion-dependent Clinical Outcome of Tumor Tracking Stereotactic Body Radiotherapy for Prostate Cancer
por: Choi, Hoon Sik, et al.
Publicado: (2018)

Combination effects of tissue heterogeneity and geometric targeting error in stereotactic body radiotherapy for lung cancer using CyberKnife
por: Kang, Ki Mun, et al.
Publicado: (2015)

Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma
por: Jeong, Bae-Kwon, et al.
Publicado: (2015)

Comparing the clinical outcomes in stereotactic body radiotherapy for lung tumors between Ray-Tracing and Monte-Carlo algorithms
por: Song, Jin Ho, et al.
Publicado: (2015)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020)

The usefulness of stereotactic radiosurgery for recursive partitioning analysis class II/III lung cancer patients with brain metastases in the modern treatment era
por: Ha, In Bong, et al.
Publicado: (2019)

MRI-based radiotherapy planning method using rigid image registration technique combined with outer body correction scheme: a feasibility study
por: Kang, Ki Mun, et al.
Publicado: (2017)

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy
por: Song, Jin Ho, et al.
Publicado: (2017)

Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors
por: Ji, Xiaoqin, et al.
Publicado: (2021)

Comprehensive Analysis of Set-Up Gain of 6-Dimensional Cone-Beam CT Correction Method in Radiotherapy for Head and Neck and Brain Tumors
por: Choi, Hoon Sik, et al.
Publicado: (2022)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity
por: Choi, Hoon Sik, et al.
Publicado: (2022)

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018)

Stereotactic Radiotherapy for Oligometastases in Lymph Nodes—A Review
por: Matsushita, Haruo, et al.
Publicado: (2018)

Synergistic Tumoricidal Effects of Alpha-Lipoic Acid and Radiotherapy on Human Breast Cancer Cells via HMGB1
por: Choi, Hoon Sik, et al.
Publicado: (2021)

Patterns of failure after resection of extrahepatic bile duct cancer: implications for adjuvant radiotherapy indication and treatment volumes
por: Choi, Hoon Sik, et al.
Publicado: (2018)

Stereotactic body radiotherapy for spinal oligometastases: a review on patient selection and the optimal methodology
por: Ito, Kei, et al.
Publicado: (2022)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Effectiveness of the Monte Carlo method in stereotactic radiation therapy applied to quasi-homogenous brain tumors
por: Kang, Ki Mun, et al.
Publicado: (2016)

Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer
por: Li, Shuai, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Jingu, Keiichi, et al.
Publicado: (2018)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
por: Choi, Hoon Sik, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group
por: Nguyen, Nam P., et al.
Publicado: (2022)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
por: Fumagalli, Ingrid, et al.
Publicado: (2012)

Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients
por: Burkon, Petr, et al.
Publicado: (2021)

Treatment outcomes of stereotactic ablative body radiotherapy on oligometastases from colorectal cancer: early results of a single institution service evaluation
por: Duong, Julie, et al.
Publicado: (2022)

Application of the new 8th TNM staging system for non-small cell lung cancer: treated with curative concurrent chemoradiotherapy
por: Choi, Hoon Sik, et al.
Publicado: (2017)

Survival, Treatment Outcome, and Safety of Multiple and Repeated Courses of Stereotactic Body Radiotherapy for Pulmonary Oligometastases of Head and Neck Squamous Cell Carcinoma
por: Vorbach, Samuel Moritz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_03rl645aucmtj04qjfbi8ce7j9